Heart Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
537
|
45
|
0.100 |
None |
1.000 |
11 |
|
2003 |
2019 |
Caffeine related disorders
|
group |
|
Mental or Behavioral Dysfunction
|
360
|
56
|
0.040 |
None |
0.750 |
4 |
4
|
2018 |
2020 |
Cardiomyopathies
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
925
|
294
|
0.440 |
None |
1.000 |
4 |
2
|
2001 |
2017 |
Diabetes Mellitus
|
group |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
2803
|
824
|
0.030 |
None |
1.000 |
3 |
|
2012 |
2019 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.030 |
None |
1.000 |
3 |
|
2001 |
2019 |
Cardiomyopathy, Dilated
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
512
|
509
|
0.020 |
None |
1.000 |
2 |
2
|
2007 |
2014 |
Ventricular Septal Defects
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Congenital Abnormality
|
426
|
87
|
0.020 |
None |
0.500 |
2 |
|
2007 |
2018 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Cardiovascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
1756
|
711
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Congenital Heart Defects
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Congenital Abnormality
|
406
|
58
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Heart valve disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
79
|
5
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Disruptive, Impulse Control, and Conduct Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
67
|
9
|
0.010 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Myopathy
|
group |
Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
634
|
166
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Nephrotic Syndrome
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
384
|
45
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Respiration Disorders
|
group |
Respiratory Tract Diseases
|
Disease or Syndrome
|
208
|
6
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Migraine Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
512
|
264
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Prion Diseases
|
group |
Infections; Nervous System Diseases
|
Disease or Syndrome
|
175
|
67
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Neurodevelopmental Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
535
|
14
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Intellectual Disability
|
group |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
2165
|
159
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cardiac Arrhythmia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
559
|
111
|
0.100 |
None |
0.971 |
69 |
6
|
2002 |
2020 |
Premature ventricular contractions
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
56
|
13
|
0.060 |
None |
0.833 |
6 |
3
|
2009 |
2018 |
Syncope
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
119
|
45
|
0.150 |
None |
1.000 |
5 |
|
2002 |
2019 |
Adverse Event Associated with Cardiac Arrhythmia
|
phenotype |
|
Disease or Syndrome
|
42
|
5
|
0.040 |
None |
1.000 |
4 |
|
2006 |
2019 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
3 |
3
|
2012 |
2019 |
Sudden death
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
30
|
3
|
0.120 |
None |
1.000 |
2 |
|
2002 |
2006 |